Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cybin Inc. (HELP.NE)

Cybin Inc. (HELP.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cybin Inc. 100 King Street West Suite 5600 Toronto ON M5X 1C9 CAN

https://www.helus.com P: 877-361-4003

Sector:

N/A

Description:

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.

Key Statistics

Overview:

Market Capitalization, $K 436,657
Shares Outstanding, K 49,894
% of Institutional Shareholders 1.39%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -79,055 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -33,722 K

Growth:

1-Year Return -17.09%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Most Recent Earnings -1.39 on 11/13/25
Next Earnings Date N/A
Earnings Per Share ttm -3.77
Dividend Payout Ratio 0.00%
Most Recent Split 1-38 on 09/19/24

HELP.NE Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -51.64%
Return-on-Assets % -45.08%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 2.32
Book Value/Share 3.78
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar